References
- Abrams B. Serum protein concentrations in normal children. Clin. Sci. 1971; 40: 67
- Aoki N., Saito H., Kamiya T., Koie K., Sakata Y., Kobakura M. Congenital deficiency of α2-plasmin inhibitor associated with severe hemorrhagic tendency. J. clin. Invest. 1979; 63: 877
- Collen D. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. Eur. J. Biochem. 1976; 69: 209
- Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thrombos. Diathes. Haemorrh. (Stuttg.) 1965; 13: 516
- Eriksson S. Studies in α1-antitrypsin deficiency. Acta med. scand. 1965, Suppl. 432: 1
- Filip D. J., Eckstein J. D., Veltkamp J. J. Hereditary antithrombin III deficiency and thromboembolic disease. Am. J. Hematol. 1976; 2: 343
- Ganrot P. O., Scherstén B. Serum α2-macro-globulin concentration and its variation with age and sex. Clin. chim. Acta 1967; 15: 113
- Harpel P. C., Cooper N. R. Studies on human plasma C1 inactivator enzyme interactions. I. Mechanisms of interaction with Cls, plasmin and trypsin. J. clin. Invest. 1975; 55: 593
- Harpel P. C., Rosenberg R. D. α2-Macroglobulin and antithrombinheparin cofactor: Modulators of hemostatic and inflammatory reactions. Progr. Hemostasis Thrombosis 1976; 3: 145
- Ibsen K. K. Blood pressure in danish children and adolescents. Acta paediatr. scand. 1981; 70: 27
- Laurell C.-B. Electroimmunoassay. Scand. J. clin. Lab. Invest. 1972, Suppl. 124: 21
- Losito R., Gattiker H., Bilodeau G., Verville N., Longpré B. Levels of antithrombin III, alpha 2-macroglobulin, and alpha 1-antitrypsin in acute ischemic heart disease. J. Lab. clin. Med. 1981; 97: 241
- Mackie M., Bennet B., Ogston D., Douglas D. S. Familial thrombosis: inherited deficiency of antithrombin III. Br. Med. J. 1978; 1: 136
- Marciniak E., Farley C. H., De Simone P. A. Familial thrombosis due to antithrombin III deficiency. Blood 1974; 43: 219
- Meade T. W., Chakrabarti R., Haines A. P., North W. R.S., Stirling Y., Thompson S. G. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; 1: 1050
- Moroi M., Aoki N. Isolation and characterization of alpha-2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. J. biol. Chem. 1976; 251: 5956
- Müllertz S. Natural inhibitors of fibrinolysis. Prog. chem. Fibrinolysis 1978; 3: 213
- Müllertz S., Clemmensen I. The primary inhibitor of plasmin in human plasma. Biochem. J. 1976; 159: 545
- Ratnoff O. D., Lepow I. H. Some properties of an esterase derived from preparations of the first component of complement. J. exp. Med. 1957; 106: 327
- Rosen F. S., Charache P., Pensky J., Donaldsson V. Hereditary angioneurotic edema: two genetic variants. Science 1965; 148: 957
- Sharp H. L., Bridges R. A., Krivit W., Freier E. F. Cirrhosis associated with α1-antitrypsin deficiency: A previously unrecognized inherited disorder. J. Lab. clin. Med. 1969; 73: 934
- Sixty plus reinfarction study research group. A double-blind trial to assess longterm oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 1980; 1: 989
- Sottrup-Jensen L., Lønblad P. B., Stepanik T. M., Petersen T. E., Magnusson S., Jörnvall H. Primary structure of the “bait” region for proteinases in α2-macroglobulin. FEBS lett. 1981; 127: 167
- Stoffersen E., Jørgensen K. A., Dyerberg J. Antithrombin III and dietary intake of polyunsaturated fatty acids. Scand. J. clin. Lab. Invest. 1982; 42: 83
- Sørensen P. J., Dyerberg J., Stoffersen E., Jensen M. K. Familial functional antithrombin III deficiency. Scand. J. Haematol. 1980; 24: 105
- Weeke B., Krasilnikoff P. A. The concentration of 21 serum proteins in normal children and adults. Acta med. scand. 1972; 192: 149